- Home
- ZURA vs JSPR Comparison
ZURA vs JSPR Comparison
Compare ZURA & JSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZURA
- JSPR
- Stock Information
- Founded
- ZURA 2022
- JSPR 2018
- Country
- ZURA United States
- JSPR United States
- Employees
- ZURA N/A
- JSPR N/A
- Industry
- ZURA Biotechnology: Biological Products (No Diagnostic Substances)
- JSPR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ZURA Health Care
- JSPR Health Care
- Exchange
- ZURA Nasdaq
- JSPR Nasdaq
- Market Cap
- ZURA 292.1M
- JSPR 325.7M
- IPO Year
- ZURA N/A
- JSPR N/A
- Fundamental
- Price
- ZURA $2.32
- JSPR $21.71
- Analyst Decision
- ZURA Buy
- JSPR Strong Buy
- Analyst Count
- ZURA 6
- JSPR 11
- Target Price
- ZURA $15.80
- JSPR $73.38
- AVG Volume (30 Days)
- ZURA 611.9K
- JSPR 184.2K
- Earning Date
- ZURA 11-07-2024
- JSPR 11-07-2024
- Dividend Yield
- ZURA N/A
- JSPR N/A
- EPS Growth
- ZURA N/A
- JSPR N/A
- EPS
- ZURA N/A
- JSPR N/A
- Revenue
- ZURA N/A
- JSPR N/A
- Revenue This Year
- ZURA N/A
- JSPR N/A
- Revenue Next Year
- ZURA N/A
- JSPR N/A
- P/E Ratio
- ZURA N/A
- JSPR N/A
- Revenue Growth
- ZURA N/A
- JSPR N/A
- 52 Week Low
- ZURA $2.00
- JSPR $5.02
- 52 Week High
- ZURA $6.35
- JSPR $31.01
- Technical
- Relative Strength Index (RSI)
- ZURA 36.40
- JSPR 49.34
- Support Level
- ZURA $2.16
- JSPR $20.77
- Resistance Level
- ZURA $2.50
- JSPR $23.11
- Average True Range (ATR)
- ZURA 0.26
- JSPR 1.67
- MACD
- ZURA 0.03
- JSPR -0.08
- Stochastic Oscillator
- ZURA 20.99
- JSPR 51.34
About ZURA Zura Bio Limited
Zura Bio Ltd is a multi-asset clinical-stage biotechnology company focused on developing novel medicines for immune and inflammatory disorders.
About JSPR Jasper Therapeutics Inc.
Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.